Overview

A Phase II Trial of Varenicline for the Treatment of Cocaine Dependence

Status:
Completed
Trial end date:
2019-06-01
Target enrollment:
Participant gender:
Summary
This is a double-blind placebo-controlled clinical trial (n = 156) of varenicline for the treatment of cocaine dependence that utilizes contingency management to promote treatment attendance.
Phase:
Phase 2
Details
Lead Sponsor:
University of Pennsylvania
Treatments:
Cocaine
Varenicline